Arcadia Investment Management’s Boston Scientific BSX Stock Holding History

Arcadia Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$879	Sell	14 -856	-98%	-$68.5K	﹤0.01%	266
2025 Q4	$83K	Buy	870 +14	+2%	+$1.37K	0.01%	158
2025 Q3	$83.6K	Hold	856	–	–	0.01%	165
2025 Q2	$91.9K	Hold	856	–	–	0.01%	160
2025 Q1	$86.4K	Hold	856	–	–	0.02%	170
2024 Q4	$76.5K	Buy	856 +230	+37%	+$20.2K	0.01%	186
2024 Q3	$52.5K	Hold	626	–	–	0.01%	182
2024 Q2	$48.2K	Hold	626	–	–	0.01%	206
2024 Q1	$42.9K	Hold	626	–	–	0.01%	212
2023 Q4	$36.2K	Hold	626	–	–	0.01%	226
2023 Q3	$33.1K	Hold	626	–	–	0.01%	237
2023 Q2	$33.9K	Buy	626 +200	+47%	+$10.4K	0.01%	241
2023 Q1	$21.3K	Hold	426	–	–	﹤0.01%	286
2022 Q4	$19.7K	Buy	426 +296	+228%	+$12.8K	﹤0.01%	276
2022 Q3	$5K	Hold	130	–	–	﹤0.01%	263
2022 Q2	$5K	Hold	130	–	–	﹤0.01%	272
2022 Q1	$6K	Hold	130	–	–	﹤0.01%	267
2021 Q4	$6K	Hold	130	–	–	﹤0.01%	270
2021 Q3	$6K	Hold	130	–	–	﹤0.01%	259
2021 Q2	$6K	Buy	+130	New	+$5.47K	﹤0.01%	273

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Arcadia Investment Management's BSX Position: Q1 2026 in Review

Arcadia Investment Management reduced its Boston Scientific (BSX) stake by 98% in Q1 2026, selling an estimated $68.5K and leaving 14 shares worth $879. The position accounts for ﹤0.01% of the portfolio, ranked #266.

Arcadia Investment Management first reported a position in BSX in Q2 2021 and has held it in 20 quarters since. The position peaked at $91.9K in Q2 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Arcadia Investment Management held 14 shares of Boston Scientific worth $879 as of Q1 2026.
Arcadia Investment Management sold 856 Boston Scientific shares in Q1 2026, an estimated $68.5K.
Boston Scientific made up ﹤0.01% of Arcadia Investment Management's portfolio in Q1 2026, its #266 holding.
Arcadia Investment Management first reported a position in Boston Scientific in Q2 2021 and has held it in 20 quarters since.
Arcadia Investment Management's Boston Scientific position peaked at $91.9K in Q2 2025.
1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.